BLOG

A thoughtfully developed tracker can provide deep insights on any therapeutic area. Using the results of a syndicated AplusA tracking study on the multiple myeloma market, this series of blog...

A thoughtfully developed tracker can provide deep insights on any therapeutic area. Using the results of a syndicated AplusA tracking study on the multiple myeloma market, this series of blog...

A thoughtfully developed tracker can provide deep insights on any therapeutic area. Using the results of a syndicated AplusA tracking study on the multiple myeloma market, this series of blog...

A thoughtfully developed tracker can provide deep insights on any therapeutic area. Using the results of a syndicated AplusA tracking study on the Multiple Myeloma market, this series of blog...

As a marketing professional in the healthcare industry, you need to accurately identify the criteria that define your specific target population in order to size your market and build your...

KOLs (Key Opinion Leaders) have long since played an important and influential role in the healthcare industry. In recent years we have seen the emergence and rapid rise in the influence of DOLs...

In the rapidly evolving onco -hematology market, syndicated research provides critical insights based on real-world data in order to support strategic decision making within pharmaceutical and ...

DLBCL is the most common form of non-Hodgkin’s lymphoma (NHL), constituting 30% to 58% of lymphoma cases.

The hematology oncology market is one of the most rapidly developing, with over sixty oncology drugs having been approved by the FDA in the last five years. Advances in targeted therapies,...

Chronic Lymphocytic Leukemia is the most common form of leukemia in Western countries. Although currently incurable, there have been significant advances in research efforts of CLL treatments in...